137,476 Shares in Astera Labs, Inc. (NASDAQ:ALAB) Acquired by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 137,476 shares of the company's stock, valued at approximately $18,209,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.08% of Astera Labs as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently bought and sold shares of ALAB. Whittier Trust Co. of Nevada Inc. purchased a new position in shares of Astera Labs in the fourth quarter valued at $25,000. Steward Partners Investment Advisory LLC increased its position in shares of Astera Labs by 99.0% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company's stock valued at $26,000 after buying an additional 99 shares in the last quarter. Kestra Investment Management LLC purchased a new position in shares of Astera Labs in the fourth quarter valued at $28,000. Geneos Wealth Management Inc. purchased a new position in shares of Astera Labs in the fourth quarter valued at $36,000. Finally, Global Retirement Partners LLC increased its position in shares of Astera Labs by 3,155.6% in the fourth quarter. Global Retirement Partners LLC now owns 293 shares of the company's stock valued at $39,000 after buying an additional 284 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on ALAB shares. Roth Capital set a $100.00 price target on Astera Labs and gave the company a "buy" rating in a research report on Wednesday, May 7th. Evercore ISI raised their price target on Astera Labs from $87.00 to $104.00 and gave the company an "outperform" rating in a research report on Wednesday, May 21st. Susquehanna started coverage on Astera Labs in a research report on Friday, May 16th. They issued a "neutral" rating and a $80.00 price target for the company. Stifel Nicolaus dropped their price target on Astera Labs from $150.00 to $100.00 and set a "buy" rating for the company in a research report on Thursday, April 17th. Finally, Citigroup dropped their price objective on Astera Labs from $120.00 to $100.00 and set a "buy" rating for the company in a research report on Monday, April 14th. One research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Astera Labs has a consensus rating of "Buy" and a consensus target price of $100.00.

Insider Activity

In other news, insider Sanjay Gajendra sold 165,000 shares of Astera Labs stock in a transaction dated Thursday, May 8th. The stock was sold at an average price of $71.76, for a total value of $11,840,400.00. Following the transaction, the insider now directly owns 755,000 shares of the company's stock, valued at $54,178,800. The trade was a 17.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Manuel Alba sold 600 shares of Astera Labs stock in a transaction dated Thursday, May 29th. The shares were sold at an average price of $100.00, for a total value of $60,000.00. Following the completion of the transaction, the director now directly owns 436,563 shares in the company, valued at $43,656,300. This represents a 0.14% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,406,640 shares of company stock valued at $122,317,670 in the last three months.

Astera Labs Trading Up 2.3%

ALAB traded up $2.17 during midday trading on Tuesday, hitting $95.09. The company's stock had a trading volume of 3,528,955 shares, compared to its average volume of 4,047,625. The firm has a market cap of $15.68 billion, a P/E ratio of -54.97, a PEG ratio of 6.18 and a beta of 0.33. The firm has a 50-day moving average price of $72.55 and a two-hundred day moving average price of $92.69. Astera Labs, Inc. has a 52-week low of $36.22 and a 52-week high of $147.39.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.05. The business had revenue of $159.44 million for the quarter, compared to analyst estimates of $151.55 million. Astera Labs had a negative return on equity of 10.40% and a negative net margin of 21.05%. The company's revenue was up 144.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.10 EPS. On average, equities analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.